BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 18617311)

  • 1. Serum concentration of NSE and S-100b during LVAD in non-resuscitated patients.
    Pfeifer R; Ferrari M; Börner A; Deufel T; Figulla HR
    Resuscitation; 2008 Oct; 79(1):46-53. PubMed ID: 18617311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation.
    Shinozaki K; Oda S; Sadahiro T; Nakamura M; Abe R; Nakada TA; Nomura F; Nakanishi K; Kitamura N; Hirasawa H
    Resuscitation; 2009 Aug; 80(8):870-5. PubMed ID: 19535196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum S-100B protein and neuron-specific enolase after traumatic brain injury].
    Sawauchi S; Taya K; Murakami S; Ishi T; Ohtsuka T; Kato N; Kaku S; Tanaka T; Morooka S; Yuhki K; Urashima M; Abe T
    No Shinkei Geka; 2005 Nov; 33(11):1073-80. PubMed ID: 16277220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-specific enolase and S-100B are associated with neurologic outcome after pediatric cardiac arrest.
    Topjian AA; Lin R; Morris MC; Ichord R; Drott H; Bayer CR; Helfaer MA; Nadkarni V
    Pediatr Crit Care Med; 2009 Jul; 10(4):479-90. PubMed ID: 19307814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest].
    Miao WL; Li HL; Wang HD; Wang J; Liu H; Ren HX; Lin HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):749-52. PubMed ID: 18093437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot study.
    Vos MJ; Postma TJ; Martens F; Uitdehaag BM; Blankenstein MA; Vandertop WP; Slotman BJ; Heimans JJ
    Anticancer Res; 2004; 24(4):2511-4. PubMed ID: 15330206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.
    Nguyen DN; Spapen H; Su F; Schiettecatte J; Shi L; Hachimi-Idrissi S; Huyghens L
    Crit Care Med; 2006 Jul; 34(7):1967-74. PubMed ID: 16607230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-100b and neuron-specific enolase in patients with fulminant hepatic failure.
    Strauss GI; Christiansen M; Møller K; Clemmesen JO; Larsen FS; Knudsen GM
    Liver Transpl; 2001 Nov; 7(11):964-70. PubMed ID: 11699032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale.
    Pfeifer R; Börner A; Krack A; Sigusch HH; Surber R; Figulla HR
    Resuscitation; 2005 Apr; 65(1):49-55. PubMed ID: 15797275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome.
    Oertel M; Schumacher U; McArthur DL; Kästner S; Böker DK
    J Clin Neurosci; 2006 Oct; 13(8):834-40. PubMed ID: 16931022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein.
    Palmio J; Huuhka M; Laine S; Huhtala H; Peltola J; Leinonen E; Suhonen J; Keränen T
    Psychiatry Res; 2010 May; 177(1-2):97-100. PubMed ID: 20378182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.
    Honda M; Tsuruta R; Kaneko T; Kasaoka S; Yagi T; Todani M; Fujita M; Izumi T; Maekawa T
    J Trauma; 2010 Jul; 69(1):104-9. PubMed ID: 20093985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs.
    Potapov EV; Loebe M; Abdul-Khaliq H; Koster A; Stein J; Sodian R; Kopitz M; Hausmann H; Noon GP; DeBakey ME; Hetzer R
    J Heart Lung Transplant; 2001 Dec; 20(12):1310-6. PubMed ID: 11744415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemofiltrastion does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Jan; 10(1):11-7. PubMed ID: 15737948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemofiltration does not influence early S-100B serum levels in septic shock patients receiving stress doses of hydrocortisone or placebo.
    Mussack T; Briegel J; Schelling G; Jochum M
    Eur J Med Res; 2005 Feb; 10(2):81-7. PubMed ID: 15817428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are serum S100beta proteins and neuron-specific enolase predictors of cerebral damage in cardiovascular surgery?
    Ishida K; Gohara T; Kawata R; Ohtake K; Morimoto Y; Sakabe T
    J Cardiothorac Vasc Anesth; 2003 Feb; 17(1):4-9. PubMed ID: 12635053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebrospinal fluid neuron-specific enolase (NSE) and S-100b protein in Guillain-Barré syndrome--their relations to prognosis].
    Mokuno K; Yasuda T; Sugimura K; Riku S; Takahashi A; Kato K
    Rinsho Shinkeigaku; 1992 May; 32(5):535-7. PubMed ID: 1458733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
    Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
    Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothermia after cardiac arrest does not affect serum levels of neuron-specific enolase and protein S-100b.
    Pfeifer R; Franz M; Figulla HR
    Acta Anaesthesiol Scand; 2014 Oct; 58(9):1093-100. PubMed ID: 25179436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.